ArticleJournal of virological methods2018
Multi-laboratory comparison of three commercially available Zika IgM enzyme-linked immunosorbent assays.
Abstract readComparative Study
In one paragraph
Article in Journal of virological methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels.Viruses · 2024Article
- Seroprevalence of Dengue, Chikungunya, and Zika viruses antibodies in a cohort of asymptomatic pregnant women in a low-income region of Minas Gerais, Brazil, 2018-2019.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
- Seroprevalence of Dengue, Chikungunya and Zika at the epicenter of the congenital microcephaly epidemic in Northeast Brazil: A population-based survey.PLoS neglected tropical diseases · 2023Article
- Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy.Pathogens (Basel, Switzerland) · 2022Review
- Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.The American journal of tropical medicine and hygiene · 2021Article
- Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.PLoS neglected tropical diseases · 2021Article
- Co-circulation and misdiagnosis led to underestimation of the 2015-2017 Zika epidemic in the Americas.PLoS neglected tropical diseases · 2021Article
- Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.PloS one · 2021Article
- Evaluation of the LIAISON XL Zika Capture IgM II for the Diagnosis of Zika Virus Infections.Viruses · 2020Article
- The Clinical Features of Co-circulating Dengue Viruses and the Absence of Dengue Hemorrhagic Fever in Pakistan.Frontiers in public health · 2020Observational
- Performance of InBios ZIKV Detect™ 2.0 IgM Capture ELISA in two reference laboratories compared to the original ZIKV Detect™ IgM Capture ELISA.Journal of virological methods · 2019Article
- Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease.Tropical medicine and infectious disease · 2019Review
- Challenges in diagnosing Zika-experiences from a reference laboratory in a non-endemic setting.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Alison Jane BasileDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States. Electronic address: ajj1@cdc.gov.
Christin GoodmanDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Kalanthe HoriuchiDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Angela SloanZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Barbara W JohnsonDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Olga KosoyDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Janeen LavenDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Amanda J PanellaDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Isabel SheetsDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Freddy MedinaDengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico, United States.
Emelissa J MendozaZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Monica EppersonMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Panagiotis ManiatisMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vera SemenovaMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Evelene Steward-ClarkMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Emily WongMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Brad J BiggerstaffDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Robert LanciottiDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Michael DrebotZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
David SafronetzZoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Jarad SchifferMicrobial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Funding
Intramural CDC HHS CC999999
Abstract
PubMed holds no abstract for this paper.
Indexed as
Enzyme-Linked Immunosorbent AssayAnimalsAntibodies, ViralChlorocebus aethiopsFemaleHumansImmunoglobulin GImmunoglobulin MMaleSensitivity and SpecificityVero CellsViral Nonstructural ProteinsZika VirusZika Virus InfectionAntibodies, ViralImmunoglobulin GImmunoglobulin MNS1 protein, zika virusViral Nonstructural ProteinsCommercialComparisonDengueELISAEnvelope EEnzyme-linked immunosorbent assayIgGIgMImmunoglobulin GImmunoglobulin MKitsNonstructural protein 1NS1VirusZika
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.